{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:47:46Z","timestamp":1791658066490,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1741,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1038\/mtna.2011.6","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T11:19:59Z","timestamp":1328613599000},"page":"e9","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Intracerebral Infusion of Antisense Oligonucleotides Into Prion-infected Mice"],"prefix":"10.1016","volume":"1","author":[{"given":"Karah","family":"Nazor Friberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed","family":"Wancewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Giles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Freier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"DeArmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Freyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lessard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Ghaemmaghami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley B","family":"Prusiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2011.6_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0006-291X(03)00805-2","article-title":"Efficient and specific down-regulation of prion protein expression by RNAi","volume":"305","author":"Tilly","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mtna.2011.6_bib2","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1242\/jcs.00494","article-title":"Specific inhibition of pathological prion protein accumulation by small interfering RNAs","volume":"116","author":"Daude","year":"2003","journal-title":"J Cell Sci"},{"key":"10.1038\/mtna.2011.6_bib3","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1172\/JCI29236","article-title":"Lentivector-mediated RNAi efficiently suppresses prion protein and prolongs survival of scrapie-infected mice","volume":"116","author":"Pfeifer","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2011.6_bib4","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.0802759105","article-title":"Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease","volume":"105","author":"White","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2011.6_bib5","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.50.3.1034-1044.2006","article-title":"Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides","volume":"50","author":"Kocisko","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1038\/mtna.2011.6_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2119\/2006-00073.Karpuj","article-title":"Phosphorothioate oligonucleotides reduce PrP levels and prion infectivity in cultured cells","volume":"13","author":"Karpuj","year":"2007","journal-title":"Mol Med"},{"key":"10.1038\/mtna.2011.6_bib7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.1090187","article-title":"Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis","volume":"302","author":"Mallucci","year":"2003","journal-title":"Science"},{"key":"10.1038\/mtna.2011.6_bib8","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1099\/vir.0.80947-0","article-title":"Prion clearance in bigenic mice","volume":"86","author":"Safar","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1038\/mtna.2011.6_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1038\/mtna.2011.6_bib10","doi-asserted-by":"crossref","first-page":"17181","DOI":"10.1074\/jbc.M311683200","article-title":"Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2011.6_bib11","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1073\/pnas.0907339106","article-title":"Measuring prions by bioluminescence imaging","volume":"106","author":"Tamg\u00fcney","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2011.6_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(02)09513-2","article-title":"Postexposure prophylaxis against prion disease with a stimulator of innate immunity","volume":"360","author":"Sethi","year":"2002","journal-title":"Lancet"},{"key":"10.1038\/mtna.2011.6_bib13","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1172\/JCI25424","article-title":"Antisense oligonucleotide therapy for neurodegenerative disease","volume":"116","author":"Smith","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1038\/mtna.2011.6_bib14","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1073\/pnas.90.22.10608","article-title":"Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies","volume":"90","author":"Prusiner","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2011.6_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF03403528","article-title":"High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene","volume":"1","author":"B\u00fceler","year":"1994","journal-title":"Mol Med"},{"key":"10.1038\/mtna.2011.6_bib16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mtna.2011.6_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0960-894X(02)00922-8","article-title":"A novel solid support for synthesis of oligonucleotide 3\u2019-phosphorothioate monoesters","volume":"13","author":"Cheruvallath","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1038\/mtna.2011.6_bib18","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1074\/jbc.274.3.1715","article-title":"Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression","volume":"274","author":"McKay","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2011.6_bib19","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1093\/nar\/gkh997","article-title":"Sequence-dependent cytotoxicity of second-generation oligonucleotides","volume":"32","author":"Drygin","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2011.6_bib20","doi-asserted-by":"crossref","first-page":"17971","DOI":"10.1073\/pnas.0708372104","article-title":"Cell division modulates prion accumulation in cultured cells","volume":"104","author":"Ghaemmaghami","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2011.6_bib21","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1073\/pnas.89.16.7620","article-title":"Regional mapping of prion proteins in brains","volume":"89","author":"Taraboulos","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2011.6_bib22","first-page":"1411","article-title":"The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease","volume":"140","author":"Muramoto","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1038\/mtna.2011.6_bib23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nm0797-750","article-title":"Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an alpha-helix","volume":"3","author":"Muramoto","year":"1997","journal-title":"Nat Med"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T05:00:01Z","timestamp":1561266001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116300671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":23,"alternative-id":["S2162253116300671"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2011.6","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"article-number":"e9"}}